electroCore, Inc. (NASDAQ:ECOR) Sees Significant Decrease in Short Interest

electroCore, Inc. (NASDAQ:ECOR) saw a large decrease in short interest in January. As of January 15th, there was short interest totalling 89,500 shares, a decrease of 22.8% from the December 31st total of 115,900 shares. Currently, 1.7% of the company’s stock are sold short. Based on an average trading volume of 124,900 shares, the days-to-cover ratio is currently 0.7 days.

Analyst Upgrades and Downgrades

Separately, HC Wainwright lifted their price objective on electroCore from $22.00 to $25.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th.

Institutional Trading of electroCore

Hedge funds and other institutional investors have recently modified their holdings of the stock. Renaissance Technologies LLC raised its holdings in electroCore by 3.4% during the 2nd quarter. Renaissance Technologies LLC now owns 68,786 shares of the company’s stock worth $442,000 after purchasing an additional 2,270 shares during the last quarter. International Assets Investment Management LLC grew its position in shares of electroCore by 689.1% during the 3rd quarter. International Assets Investment Management LLC now owns 535,146 shares of the company’s stock worth $3,864,000 after buying an additional 467,326 shares during the period. HighTower Advisors LLC bought a new stake in shares of electroCore during the third quarter worth approximately $255,000. Finally, Geode Capital Management LLC boosted its stake in electroCore by 10.3% in the third quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock valued at $458,000 after acquiring an additional 5,951 shares during the last quarter. Institutional investors and hedge funds own 26.74% of the company’s stock.

electroCore Stock Up 6.4 %

NASDAQ:ECOR traded up $1.01 on Friday, reaching $16.72. The stock had a trading volume of 90,335 shares, compared to its average volume of 91,298. The company has a market capitalization of $111.36 million, a P/E ratio of -9.14 and a beta of 0.50. The stock has a fifty day moving average price of $14.99 and a 200-day moving average price of $10.28. electroCore has a 1-year low of $5.32 and a 1-year high of $18.67.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.